BD Statement On European Commission Conditional Clearance Of Bard Acquisition

FRANKLIN LAKES, N.J., Oct. 18, 2017 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, issued the following statement regarding today’s clearance by the European Commission for BD to acquire C.R. Bard (NYSE: BCR), contingent on BD divesting its soft tissue core needle biopsy product line: “We continue to make... Read more

Acquisition of The Omnicon Group, Inc.

18 October 2017 – Spectris plc (‘Spectris’) (LSE: SXS), the productivity-enhancing instrumentation and controls company, today announces that it has completed the acquisition of the privately-held US company The Omnicon Group, Inc. (‘Omnicon’) for an initial consideration of $29 million. Omnicon provides a range of services to help its customers analyse and improve product reliability... Read more

The Jackson Laboratory and Seven Bridges Collaborate to Build Centralized Data Platform to Advance Cancer Research

October 17, 2017 National Cancer Institute awards $2M grant to fund joint PDX data center to integrate, share, and analyze cancer treatment data for research community FARMINGTON, Conn., and BOSTON, Mass., October 17, 2017 – The Jackson Laboratory (JAX), a nonprofit biomedical research institution, and Seven Bridges, the leading biomedical data analysis company, today announced a new collaboration to... Read more

ZEISS signed strategic partnership agreement with Xnovo

JENA/Germany, KØGE/Denmark, 2017-10-17. The ZEISS Microscopy business group announced today that it has signed an exclusive strategic partnership agreement with Denmark-based Xnovo Technology ApS, a company that develops innovative software-based 3D X-ray imaging and analysis solutions. The two companies have already been working together over the past two years. This strategic partnership is targeting to... Read more

10x Genomics Announces Automated Workflow for Dried Blood Spot and Saliva for Linked-Read Sequencing.

–Automated workflow will enable population and genetic health studies– PLEASANTON, Calif.—October 12, 2017—10x Genomics, a company focused on enabling the mastery of biology by accelerating genomic discovery, today announced a new automation solution for whole genome and exome sequencing developed in collaboration with PerkinElmer, Inc. The new workflow allows Linked-Read sequencing to be performed on... Read more

Two Pore Guys Announces Global Licensing Agreement With Monsanto for Its Rapid Detection Technology Platform

Announcement marks 2PG’s first agriculture agreement; Initial assays will target biomolecule detection in crops, pests and pathogens to improve lab and in-field testing efficiencies October 12, 2017 04:30 AM Pacific Daylight Time SANTA CRUZ, Calif.–(BUSINESS WIRE)–Two Pore Guys, Inc. (2PG), announced today that it has entered into an agreement with Monsanto Company that will enable... Read more

Gyros Protein Technologies signs distribution agreement with Euro Diagnostica

Gyros Protein Technologies becomes distributor of iLite® cell-based reporter gene assays for drug development   Uppsala and Malmö, Sweden, 11 October 2017: Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, today announced it has signed a distribution agreement withEuro Diagnostica, the full service assay solution company.... Read more

Shimadzu Scientific Instruments, Inc. and VpH, a division of Vyripharm Biopharmaceuticals, Establish the Medical Botanical Center of Excellence at University of Houston Innovation Center

The First Comprehensive Botanical Testing Platform Will Ensure Quality Control/Quality Assurance, and Validation/Verification for Patient Safety and Drug Efficacy in Texas HOUSTON, Oct. 10, 2017 /PRNewswire/ — Shimadzu Instrumentation Corporation announces a collaboration with VpH, to establish the Medical Botanical Center of Excellence. The Center represents the first fully comprehensive pharmaceutical grade Medical Botanical Testing Platform in Texas. The... Read more